Latest Posts › Centers for Disease Control and Prevention (CDC)

Share:

COVID-19 Weekly Newsletter: Vaccine Approved for Children, OSHA Vaccination Mandate

Efforts to continue to promote and expand access to COVID-19 vaccines reached major milestones this week, as the holiday season draws near. OSHA Vaccination Mandate - In early September, President Biden released a...more

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

COVID-19 Weekly Newsletter: Additional Booster Shots Recommended as FDA Prepares to Evaluate Vaccines for Younger Children

Booster Shot Endorsements - Last week, the U.S. Food and Drug Administration (FDA) advisory committee endorsed one of the mRNA COVID-19 vaccines and the single-dose vaccine to be used as a booster shot. This week, FDA...more

COVID-19 Weekly Newsletter: FDA Considers COVID-19 Pill, Travel Restrictions To Be Lifted

A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more

COVID-19 Weekly Newsletter: A Pill To Treat COVID-19?

A promising new COVID-19 treatment grabbed headlines this week, along with new updates on one mRNA vaccine manufacturer’s path to potentially seeking Food and Drug Administration (FDA) approval on vaccines for children...more

COVID-19 Weekly Newsletter: Domestic and International Vaccine News

Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more

COVID-19 Weekly Newsletter: Updates on Vaccines for Children and Potential Authorization for Booster Shots

Amid continued spread of the Delta variant and sobering new studies about the toll COVID-19 has exacted on medical staff, vaccine manufacturers and public health leaders continue to seek solutions — including efforts to...more

COVID-19 Weekly Newsletter: EU Restricts Travel, U.S. Boosts Vaccine Supply Chain

The European Union removed the U.S. from its safe travel list earlier this week, as the Biden administration took measures to bolster the vaccine supply chain to meet the anticipated rise in demand. Children Account for...more

COVID-19 Weekly Newsletter: Booster Shots Continue To Gain Steam

Recent announcements on the prospect of booster shots for all vaccinated Americans, a vaccine mandate for staff at federally funded nursing homes and an encouraging uptick in vaccinations marked an eventful week in the...more

COVID-19 Weekly Newsletter: Formidable Delta Variant Prompts Vaccine Mandates

Vaccinated Individuals Infected With Delta Variant May Carry as Much Virus as Unvaccinated - The U.S. Centers for Disease Control and Prevention (CDC) updated their mask guidance on July 27, 2021, recommending that...more

COVID-19 Weekly Newsletter: CDC Updates Guidance

New federal guidance on masking and testing highlighted an eventful week in the COVID-19 response, as government authorities work to respond to the rising transmission of the Delta variant. CDC Updates Masking and...more

COVID-19 Weekly Newsletter: Combating the Delta Variant

As the Delta variant becomes more prevalent — and its severity better understood — public health authorities look to apply lessons from earlier waves of the COVID-19 pandemic to help curb the recent rise in cases. The latest...more

COVID-19 Weekly Newsletter: Variant Reduces Vaccine Efficacy but There Is Disagreement on Need for Boosters

Vaccine Manufacturer and Government Agencies Disagree on Need for Booster Shots - A manufacturer of an mRNA COVID-19 vaccine stated they are observing decreased immunity from its vaccine and issued a statement saying they...more

COVID-19 Weekly Newsletter: U.S. Vaccination Effort Goes International

While actively launching new initiatives and incentives to boost the vaccination rate within its own population, the U.S. government this week announced its plans to share portions of its vaccine stockpile...more

COVID-19 Weekly Newsletter: 60% of American Adults Have Received One Vaccine Dose

With vaccination rates climbing, this week marked an encouraging turn on the path to a more “normal” summer and avoiding a fall resurgence. FDA Opposes Antibody Testing To Evaluate Immunity Response - On Wednesday,...more

COVID-19 Weekly Newsletter: Positive Signs on Path to Normalcy, Teenagers Approved for Vaccines

The Centers for Disease Control and Prevention (CDC) made waves this week with its announcement that fully vaccinated individuals can begin congregating indoors. Coupled with the announcement that teenagers are eligible for...more

COVID-19 Weekly Newsletter: Guidance and Developments as Global Vaccination Continues

This week, the CDC announced updated guidance regarding outdoor gatherings, and the Department of Labor is advancing new workplace safety standards. Meanwhile, dwindling U.S. vaccination rates and global vaccine access are...more

COVID-19 Weekly Newsletter: An Annual COVID-19 Booster?

Vaccine news dominated the COVID-19 headlines this week, as the ongoing vaccine roll-out hit a snag and leaders contemplated the potential for annual COVID-19 booster shots....more

COVID-19 Weekly Newsletter: Vaccine Progress Continues in U.S.

With a vaccination rate of 49 doses administered per 100 people, the United States has administered a higher number of vaccines than any country in the world. As the federal government looks to keep the vaccine rollout...more

COVID-19 Weekly Newsletter: Preventing the Next Pandemic

A recent study of one of the two mRNA-based vaccines revealed positive news on how long the vaccine will effectively prevent against COVID-19 infection. The pandemic has also revealed societal weaknesses that, if addressed,...more

COVID-19 Weekly Newsletter: COVID-19 Relief, Vaccine Rollout Update

It was a week of welcome news and encouraging milestones in the COVID-19 response, especially in the U.S., where the federal government passed a $1.9 trillion COVID-19 relief package and President Biden announced a goal to...more

COVID-19 Weekly Newsletter: Leaders Ponder Return to Normalcy

With significant headway in the vaccine distribution and certain states already lifting COVID-19 restrictions, U.S. leaders are beginning to contemplate when we might return to some semblance of normalcy. Two Million...more

COVID-19 Weekly Newsletter: CDC Releases Guidance for Vaccinated Population

New guidance from the Centers for Disease Control and Prevention (CDC) and vaccine news from the White House highlight another week in the COVID-19 vaccine rollout. New CDC Findings and Recommendations - According to...more

COVID-19 Weekly Newsletter: Biden Announces Ambitious Vaccination Plan

With Inauguration Day rapidly approaching, President-elect Biden has announced an ambitious vaccination plan, and the federal government has signaled a change to its vaccine distribution process, among other COVID-19...more

COVID-19 Weekly Newsletter: U.S. Suffers Deadliest Days for COVID-19

In an otherwise troubling week, there are some positive developments in the COVID-19 response, including progress in the development of a new vaccine. The Pandemic Is Far from Over: 4000 Lives Gone in One Day ...more

30 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide